Clinical Trial Update: Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures [Phase 3]

View source ↗

Summary

Phase 3 trial assessing long-term safety and efficacy of zonisamide as monotherapy for newly diagnosed partial seizures; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Seizures

Drugs mentioned

• Zonegran (zonisamide)

Snippet

Sponsor: Eisai Inc. | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2013-01-15